Lactobacillus plantarum and Bifidobacterium longum Alleviate Liver Injury and Fibrosis in Mice by Regulating NF-κB and AMPK Signaling
Journal of Microbiology and Biotechnology · 2024
DOI: 10.4014/jmb.2310.10006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Microbiology and Biotechnology, 2024. Verfasst von Dong-Yun Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Neurobiota Research Center, College of Pharmacy, Kyung Hee University, Seoul 02447, Republic of Korea. Hauptthemen laut MEDLINE: Lactiplantibacillus plantarum, Bifidobacterium longum. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ministry of Food and Drug Safety, Korea Healthy Industry Development Institute, National Research Foundation of Korea.
Abstract (Originalsprache)
In a preliminary study, live biotherapeutic products (LBPs) Lactobacillus plantarum LC27 and Bifidobacterium longum LC67 inhibited the secretion of alanine transaminase (ALT) and aspartate transaminase (AST) in LPS-stimulated HepG2 cells, while Escherichia coli K1 (Ec) increased ALT and ALT secretion. Therefore, we examined the effects of LC27 and LC67 on LPS-induced liver injury and fibrosis in mice and the correlation between their biomarkers in cell and animal experiments. Orally administered LC27 or LC67 significantly decreased blood ALT, AST, γ-glutamyl transferase (γGTP), TNF-α, triglyceride (TG), total cholesterol (TCh), total bile acid, and LPS levels, liver TNF-α, toll-like receptor-4 gene (Tlr4), α-smooth muscle actin (αSMA), and collagen-1 expression and αSMA+GFAP+ and NF-κB+F4/80+ cell populations, and colonic Tlr4, TNF-α, and IL-6 expression and NF-κB-positive cell population in LPS-treated mice. Furthermore, they increased AMPKa phosphorylation in the liver and colon. However, Ec increased the expression of TNF-α and IL-6 in blood, liver, and colon. The suppression of LPS-stimulated ALT and AST secretion in HepG2 cells by LBPs was positively correlated with their ameliorating effects on LPS-induced blood γGTP, ALT, and AST levels and liver αSMA and collagen-1 expression in mice. Based on these findings, LC27 and LC67 may improve liver injury and fibrosis by regulating NF-κB and AMPK signaling pathway and a protocol that can assay the inhibitory activity of LBPs on LPS-induced ALT and AST secretion in HepG2 may be useful for guessing their antihepatitic effects in the in vivo experiments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neurobiota Research Center, College of Pharmacy, Kyung Hee University, Seoul 02447, Republic of Korea.
- PB Department, NVP Healthcare, Inc., Suwon 16209, Republic of Korea.
Förderung
- Ministry of Food and Drug Safety
- Korea Healthy Industry Development Institute
- National Research Foundation of Korea
- Ministry of Science and ICT
Zitieren
APA
Lee, D. Y., Shin, J. W., Shin, Y. J., Han, S. W., & Kim, D. H. (2024). Lactobacillus plantarum and Bifidobacterium longum Alleviate Liver Injury and Fibrosis in Mice by Regulating NF-κB and AMPK Signaling. Journal of Microbiology and Biotechnology. https://doi.org/10.4014/jmb.2310.10006
Vancouver
Lee DY, Shin JW, Shin YJ, Han SW, Kim DH. Lactobacillus plantarum and Bifidobacterium longum Alleviate Liver Injury and Fibrosis in Mice by Regulating NF-κB and AMPK Signaling. Journal of Microbiology and Biotechnology. 2024. doi:10.4014/jmb.2310.10006
BibTeX
@article{Lee2024,
author = {Lee, Dong-Yun and Shin, Jung-Woo and Shin, Yoon-Jung and Han, Seung-Won and Kim, Dong-Hyun},
title = {Lactobacillus plantarum and Bifidobacterium longum Alleviate Liver Injury and Fibrosis in Mice by Regulating NF-κB and AMPK Signaling},
journal = {Journal of Microbiology and Biotechnology},
year = {2024},
doi = {10.4014/jmb.2310.10006}
}
EUVIMED